UBS OCONNOR LLC - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 84 filers reported holding ANTARES PHARMA INC in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q3 2015$340,000,000
-72.8%
200,000
-66.7%
0.01%
-68.2%
Q2 2015$1,248,000,000
+212.0%
600,000
+300.0%
0.02%
+175.0%
Q2 2014$400,000,000
-48.1%
150,000
-31.8%
0.01%
-46.7%
Q1 2014$770,000,000
-31.2%
220,000
-12.0%
0.02%
-28.6%
Q4 2013$1,120,000,000
+3.7%
250,000
-6.0%
0.02%
-4.5%
Q3 2013$1,080,000,000
-45.3%
266,000
-44.0%
0.02%
-40.5%
Q2 2013$1,976,000,000475,0000.04%
Other shareholders
ANTARES PHARMA INC shareholders Q4 2013
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,130,192$12,834,0005.32%
Velan Capital Investment Management LP 1,346,971$5,523,0005.12%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,799,953$11,480,0004.03%
Sargent Investment Group, LLC 3,663,275$15,019,0003.78%
PERKINS CAPITAL MANAGEMENT INC 481,483$1,974,0001.62%
Rubric Capital Management LP 10,900,000$44,690,0001.62%
ORACLE INVESTMENT MANAGEMENT INC 1,720,000$7,052,0001.39%
Long Focus Capital Management, LLC 540,000$2,214,0000.28%
OBERWEIS ASSET MANAGEMENT INC/ 344,200$1,411,0000.28%
FIRETHORN WEALTH PARTNERS, LLC 84,069$345,0000.26%
View complete list of ANTARES PHARMA INC shareholders